VYNE Therapeutics to Participate in the 2nd Annual JAK Inhibitors Drug Development Digital Event
BRIDGEWATER, N.J., June 29, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that...
Month: June 2021
Paratek Pharmaceuticals Announces First BARDA Project BioShield Procurement of NUZYRA® (omadacycline) Valued at ~$38 Million
-- First BARDA Procurement has been Delivered and Revenue will be Recognized in Second Quarter 2021BOSTON, June 29, 2021 (GLOBE...
Allied Corp Signs Psilocybin Manufacturing Agreement To Produce Psilonex™ RX For What We Believe To Be The Largest Known Psilocybin Patient Cohort In The World
KELOWNA, British Columbia., June 29, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical...
H-CYTE Announces Publication of Positive Real-World Data Relating to the Use of Innovative Treatment (PRP-PBMC) Aimed at Helping Improve Overall Lung Health
Statistically Significant Improvement in Pulmonary Function at Both 3 Months and 12 Months Post TreatmentTAMPA, Fla., June 29, 2021 (GLOBE...
Propella Announces First Patient Dosed in Phase 1/2a Trial of PRL-02 for Treatment of Metastatic Prostate Cancer
Next-Generation Androgen Biosynthesis Inhibitor with Long Duration of Activity and Superior Therapeutic IndexPITTSBORO, N.C., June 29, 2021 (GLOBE NEWSWIRE) --...
Reneo Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices
SAN DIEGO, June 29, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on...
Cend Therapeutics’ CEND-1 Granted Fast Track Designation for Pancreatic Cancer
SAN DIEGO, June 29, 2021 (GLOBE NEWSWIRE) -- The US Food and Drug Administration (FDA) has granted Fast Track Development...
Elicio Therapeutics Announces Initiation of Its Phase 1/2 Dose-Escalation Study of ELI-002 (AMPLIFY-201) in KRAS-Driven Cancers
Study will evaluate the safety and preliminary efficacy of ELI-002, an investigational lymph node-targeted therapeutic vaccine in patients with KRAS-driven...
Cullinan Oncology Receives FDA Clearance of Investigational New Drug (IND) Application for CLN-619, a Novel MICA/B-targeted Antibody for the Treatment of Solid Tumors
CLN-619 will be the first MICA/B-targeted antibody to enter human clinical trialsCullinan will initiate a FIH trial in 3Q21, including...
vTv Therapeutics to Participate at the 6th World Psoriasis & Psoriatic Arthritis Conference with Poster Presentation on HPP737
HIGH POINT, N.C., June 29, 2021 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the...
Auxly Announces Results of Annual General and Special Meeting of Shareholders
TORONTO, June 29, 2021 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX- XLY) (OTCQX: CBWTF) ("Auxly" or the "Company") announced...
Acerus Announces New PBM Contract, Significantly Expanding NATESTO® Insurance Coverage in the United States
NATESTO® Coverage now Includes 85% of Commercial LivesTORONTO, June 29, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF), a...
USA Equities Corp Announces the Signing of a Distribution Agreement with a Prominent Physician Management Services Firm For its AllergiEnd® Products and Services
-Continued Momentum Expanding Independent Care Practitioner Network- West Palm Beach, FL, June 29, 2021 (GLOBE NEWSWIRE) -- USA Equities Corp....
Avicanna and Bio-Gate Complete First Phase of Development on Cannabidiol (CBD) and MicroSilver BG™ Based Skin Care Products for Global Commercialization
Initial development is part of a licensing and development agreement between the two companies to develop and deliver dermatology and...
CicloMed Announces Initiation of Phase 1B Trial of Fosciclopirox in Newly Diagnosed and Recurrent Urothelial Cancer Patients
Small Business Innovation Research Grant from National Cancer Institute Enables Phase 1B TrialKANSAS CITY, Mo., June 29, 2021 (GLOBE NEWSWIRE)...
TG Therapeutics Mourns the Loss of Board Member, William J. Kennedy, PhD
NEW YORK, June 29, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced with great sadness the passing...
Zealand Pharma to Present Data on Glepaglutide at the 17th Congress of the Intestinal Rehabilitation and Transplantation Association (CIRTA)
Company announcement – No. 43/ 2021 Zealand Pharma to Present Data on Glepaglutide at the 17th Congress of the Intestinal...
InMed Pharmaceuticals Signs Non-binding Letter of Intent to Acquire BayMedica, a Commercial Manufacturer of Rare Cannabinoids
VANCOUVER, British Columbia, June 29, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a clinical-stage...
Renovacor Announces the Appointments of Joan Lau, Ph.D., and Gregory F. Covino to its Board of Directors
Appointments to be effective upon closing of the previously announced merger between Renovacor and Chardan Healthcare Acquisition 2 Corp.PHILADELPHIA, June...
Microbot Medical Secures Patent Allowance in China; Third Global Jurisdiction in 2021 to Recognize Novelty of ‘One & Done’ Technology
HINGHAM, Mass., June 29, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that China has become the latest...